Stocks Hit Lows Amid Broad Market Volatility

Several companies, including Cadre Holdings, E2open Parent Holdings, and Agilent Technologies, have recently seen their stocks hit 52-week lows amid challenging market conditions. Cadre Holdings, despite a stock dip, reported strong revenue growth and a strategic acquisition in the nuclear safety sector. E2open's financial results revealed a mixed performance with a significant goodwill impairment, while Agilent Technologies exceeded Q1 earnings expectations and maintained its full-year guidance, with new approvals for its diagnostics kit in the EU. Companies like Chardan Nextech and Homology Medicines have suffered significant stock declines, reflecting broader economic pressures, with Homology Medicines trading 96% below its 52-week high. Despite these downturns, some stocks like Nanometrics and Onto Innovation show potential upside according to analyst targets, suggesting opportunities for recovery.